Insightful Look at Doma Holdings Shares Surge By 34% in Pre-Market Trading

Shares of Doma Holdings Inc.
DOMA rose sharply in today’s pre-market
trading after the company entered a merger transaction with TRG to go private at $6.29 per share in cash.

Doma Holdings shares jumped 34.1% to $6.09 in pre-market trading

Here are some other stocks moving in pre-market trading.

Major Gains

• Vast Renewables Limited
  VSTE rose 213.9% to $9.70 in
  pre-market trading after jumping 39% on Thursday.
• MediaCo Holding Inc.
  MDIA gained 84% to $0.9601 in pre-market
  trading after dipping more than 17% on Thursday.
• Galera Therapeutics, Inc.
  GRTX gained 49.5% to $0.2093 in pre-market
  trading. Galera Therapeutics posted fourth-quarter results on Thursday.
• Qilian International Holding Group Limited
  QLI shares gained 32.2% to $0.8399 in
  pre-market trading.
• Sunshine Biopharma, Inc.
  SBFM gained 30.7% to $0.0791 in pre-market
  trading after the company reported operating results for the fiscal year ended Dec. 31, 2023.
• Xilio Therapeutics, Inc.
  XLO shares rose 26.8% to $1.37 in pre-market
  trading. Xilio Therapeutics shares jumped 69% on Thursday after the company announced an exclusive
  license agreement with Gilead Sciences for a tumor-activated IL-12 program.
• Zapata Computing Holdings Inc.
  ZPTA gained 10.3% to $15.01 in pre-market
  trading.
• Torrid Holdings Inc.
  CURV shares rose 13.9% to $5.5579 in
  pre-market trading after the company reported better-than-expected fourth-quarter financial results.
• PAVmed Inc.
  PAVM climbed 8% to $2.31 in pre-market
  trading after dipping over 20% on Thursday.

Movers in Reverse

• Mountain Crest Acquisition Corp. IV
  MCAF fell 58.7% to $5.99 pre-market trading.
  CH Auto Technology and Mountain Crest Acquisition Corp. IV completed transformative business
  combination.
• Fractyl Health, Inc.
  GUTS declined 28.9% to $5.26 in pre-market
  trading after the company received FDA IDE approval for Revita Remain-1 study for obesity after
  discontinuation of GLP-1 based drugs. The company also reported fourth-quarter results.
• ENDRA Life Sciences Inc.
  NDRA shares dropped 28.3% to $0.4157 in
  pre-market trading after the company reported fourth-quarter results.
• X3 Holdings Co Ltd.
  XTKG fell 28.1% to $0.7118 in pre-market
  trading after the company unveiled its strategic partnership with a leading provider of semiconductor
  modules and devices..
• Sintx Technologies, Inc.
  SINT fell 22.8% to $0.0382 in pre-market
  trading after announcing a proposed public offering of common stock.
• Vivos Therapeutics, Inc.
  VVOS fell 18.8% to $3.9220 pre-market
  trading after reporting quarterly results.
• Avalo Therapeutics, Inc.
  AVTX fell 16.4% to $18.19 in pre-market
  trading following FY2023 results.
• Applied Therapeutics, Inc.
  APLT shares tumbled 14.7% to $5.80 in pre-market
  trading after the company announced that the FDA extended the review period for the NDA for govorestat
  for the treatment of Classic Galactosemia by three months.
• CleanSpark, Inc.
  CLSK shares fell 12.3% to $18.60 in pre-market
  trading after declining over 8% on Thursday. Cantor Fitzgerald analyst Josh Siegler maintained Cleanspark
  with an Overweight and raised the price target from $10 to $20 on Thursday.
• Oxford Industries, Inc.
  OXM fell 6% to $105.68 in pre-market
  trading as the company reported downbeat financial results for its fourth quarter and issued weak
  guidance for the first quarter.

 

Now Read This: Top 2 Energy Stocks That Are Preparing To Pump In April